1011738
Last Update Posted: 2017-04-10
Recruiting has ended
All Genders accepted | 18 Years + |
1842 Estimated Participants | No Expanded Access |
Observational Study | Does not accept healthy volunteers |
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
This observational, non-interventional cohort study will evaluate predictors of response in patients with chronic hepatitis B receiving standard of care Pegasys therapy. Efficacy and safety parameters will also be evaluated. Patients included in the study will be followed for the duration of their treatment and for up to 3 years thereafter.
Eligibility
Relevant conditions:
Hepatitis B, Chronic
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Contact Information
Overall Contact
No valid contacts available
Data sourced from ClinicalTrials.gov